(19)
(11) EP 1 815 803 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
05.10.2011 Bulletin 2011/40

(45) Mention of the grant of the patent:
18.05.2011 Bulletin 2011/20

(21) Application number: 07075291.0

(22) Date of filing: 22.06.2000
(51) International Patent Classification (IPC): 
A61B 17/064(2006.01)
 A61B 17/068(2006.01)

(54)

Gerd treatment apparatus

GERD Gewebe-Rekonfiguration

Reconfiguration de tissus GERD

(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 22.06.1999 US 140492 P
07.03.2000 US 520273
07.03.2000 US 519945
19.05.2000 US 574424

(43) Date of publication of application:
08.08.2007 Bulletin 2007/32

(62) Application number of the earlier application in accordance with Art. 76 EPC:
00943084.4 / 1187559

(73) Proprietor: Ethicon Endo-Surgery, Inc.
Cincinnati, Ohio 45242-2839 (US)

(72) Inventors:
  • Laufer, Michael D.
    Menlo Park, CA 94025 (US)
  • Cerier, Jeffrey C.
    Franklin, MA 02038 (US)
  • Cruz, Amos G.
    Franklin, MA 02038 (US)

(74) Representative: Tunstall, Christopher Stephen et al
Carpmaels & Ransford One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)


(56) References cited: : 
EP-A1- 0 593 920
WO-A-99/22649
US-A- 5 897 562
 WO-A-89/11827
US-A- 5 403 326
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).